Apellis Pharmaceuticals Down Nearly 24%, on Pace for Largest Percent Decrease Since July 2023 -- Data Talk

Dow Jones

Oct 30, 2025

Apellis Pharmaceuticals, Inc. ( APLS ) is currently at $22.86, down $7.19 or 23.93%

--Would be lowest close since Sept. 30, 2025, when it closed at $22.63

--On pace for largest percent decrease since July 17, 2023, when it fell 37.92%

--Snaps a three day winning streak

--Up 1.02% month-to-date; on pace for best month since Aug. 2025, when it rose 23.41%

--Down 28.36% year-to-date

--Down 75.5% from its all-time closing high of $93.31 on June 13, 2023

--Down 16.14% from 52 weeks ago (Oct. 31, 2024), when it closed at $27.26

--Down 35.46% from its 52-week closing high of $35.42 on Dec. 2, 2024

--Up 39.73% from its 52-week closing low of $16.36 on May 15, 2025

--Traded as low as $22.82; lowest intraday level since Oct. 1, 2025, when it hit $22.79

--Down 24.08% at today's intraday low; largest intraday percent decrease since Dec. 14, 2023, when it fell as much as 26.15%

All data as of 11:36:57 AM ET

Source: Dow Jones Market Data, FactSet

(END) Dow Jones Newswires

October 30, 2025 11:40 ET (15:40 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

At the request of the copyright holder, you need to log in to view this content

LOGIN / SIGN UP

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2579140121"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2579140121\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2579140121?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-10-30 23:40","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2579140121","market":"sg","top_or_hot":-1,"title":"Apellis Pharmaceuticals Down Nearly 24%, on Pace for Largest Percent Decrease Since July 2023 -- Data Talk","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n  Apellis Pharmaceuticals, Inc. ( APLS ) is currently at $22.86, down $7.19 or 23.93% \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n     --Would be lowest close since Sept. 30, 2025, when it closed at $22.63 \n</p>\n<p>\n     --On pace for largest percent decrease since July 17, 2023, when it fell 37.92% \n</p>\n<p>\n     --Snaps a three day winning streak \n</p>\n<p>\n     --Up 1.02% month-to-date; on pace for best month since Aug. 2025, when it rose 23.41% \n</p>\n<p>\n     --Down 28.36% year-to-date \n</p>\n<p>\n     --Down 75.5% from its all-time closing high of $93.31 on June 13, 2023 \n</p>\n<p>\n     --Down 16.14% from 52 weeks ago (Oct. 31, 2024), when it closed at $27.26 \n</p>\n<p>\n     --Down 35.46% from its 52-week closing high of $35.42 on Dec. 2, 2024 \n</p>\n<p>\n     --Up 39.73% from its 52-week closing low of $16.36 on May 15, 2025 \n</p>\n<p>\n     --Traded as low as $22.82; lowest intraday level since Oct. 1, 2025, when it hit $22.79 \n</p>\n<p>\n     --Down 24.08% at today's intraday low; largest intraday percent decrease since Dec. 14, 2023, when it fell as much as 26.15% \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n     All data as of 11:36:57 AM ET \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n     Source: Dow Jones Market Data, FactSet \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  October 30, 2025 11:40 ET (15:40 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Apellis Pharmaceuticals Down Nearly 24%, on Pace for Largest Percent Decrease Since July 2023 -- Data Talk</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nApellis Pharmaceuticals Down Nearly 24%, on Pace for Largest Percent Decrease Since July 2023 -- Data Talk\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2025-10-30 23:40</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n  Apellis Pharmaceuticals, Inc. ( APLS ) is currently at $22.86, down $7.19 or 23.93% \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n     --Would be lowest close since Sept. 30, 2025, when it closed at $22.63 \n</p>\n<p>\n     --On pace for largest percent decrease since July 17, 2023, when it fell 37.92% \n</p>\n<p>\n     --Snaps a three day winning streak \n</p>\n<p>\n     --Up 1.02% month-to-date; on pace for best month since Aug. 2025, when it rose 23.41% \n</p>\n<p>\n     --Down 28.36% year-to-date \n</p>\n<p>\n     --Down 75.5% from its all-time closing high of $93.31 on June 13, 2023 \n</p>\n<p>\n     --Down 16.14% from 52 weeks ago (Oct. 31, 2024), when it closed at $27.26 \n</p>\n<p>\n     --Down 35.46% from its 52-week closing high of $35.42 on Dec. 2, 2024 \n</p>\n<p>\n     --Up 39.73% from its 52-week closing low of $16.36 on May 15, 2025 \n</p>\n<p>\n     --Traded as low as $22.82; lowest intraday level since Oct. 1, 2025, when it hit $22.79 \n</p>\n<p>\n     --Down 24.08% at today's intraday low; largest intraday percent decrease since Dec. 14, 2023, when it fell as much as 26.15% \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n     All data as of 11:36:57 AM ET \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n     Source: Dow Jones Market Data, FactSet \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  October 30, 2025 11:40 ET (15:40 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4139","symbol_name":"生物科技","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2579140121","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2579140121","pubTimestamp":1761838800,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"Apellis Pharmaceuticals, Inc.  is currently at $22.86, down $7.19 or 23.93%. --Would be lowest close since Sept. 30, 2025, when it closed at $22.63. --On pace for largest percent decrease since July 17, 2023, when it fell 37.92%. --Up 1.02% month-to-date; on pace for best month since Aug. 2025, when it rose 23.41%. --Down 75.5% from its all-time closing high of $93.31 on June 13, 2023. --Down 16.14% from 52 weeks ago , when it closed at $27.26. --Down 35.46% from its 52-week closing high of $35.42 on Dec. 2, 2024. --Up 39.73% from its 52-week closing low of $16.36 on May 15, 2025. --Traded as low as $22.82; lowest intraday level since Oct. 1, 2025, when it hit $22.79. --Down 24.08% at today's intraday low; largest intraday percent decrease since Dec. 14, 2023, when it fell as much as 26.15%","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4139":"生物科技","LU1093756325.SGD":"FTIF - Franklin K2 Alt Strat Fd A (acc) SGD-H1","APLS":"Apellis Pharmaceuticals Inc.","LU1093756168.USD":"FRANKLIN K2 ALTERNATIVE STRATEGIES \"A\" (USD) ACC","BK4588":"碎股","BK4505":"高瓴资本持仓","BK4585":"ETF&股票定投概念"},"translate_title":"Apellis Pharmaceuticals下跌近24%，创2023年7月以来最大跌幅——Data Talk","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"APLS":0.9},"content_text":"Apellis Pharmaceuticals, Inc. ( APLS ) is currently at $22.86, down $7.19 or 23.93% \n\n\n \n\n\n     --Would be lowest close since Sept. 30, 2025, when it closed at $22.63 \n\n\n     --On pace for largest percent decrease since July 17, 2023, when it fell 37.92% \n\n\n     --Snaps a three day winning streak \n\n\n     --Up 1.02% month-to-date; on pace for best month since Aug. 2025, when it rose 23.41% \n\n\n     --Down 28.36% year-to-date \n\n\n     --Down 75.5% from its all-time closing high of $93.31 on June 13, 2023 \n\n\n     --Down 16.14% from 52 weeks ago (Oct. 31, 2024), when it closed at $27.26 \n\n\n     --Down 35.46% from its 52-week closing high of $35.42 on Dec. 2, 2024 \n\n\n     --Up 39.73% from its 52-week closing low of $16.36 on May 15, 2025 \n\n\n     --Traded as low as $22.82; lowest intraday level since Oct. 1, 2025, when it hit $22.79 \n\n\n     --Down 24.08% at today's intraday low; largest intraday percent decrease since Dec. 14, 2023, when it fell as much as 26.15% \n\n\n \n\n\n     All data as of 11:36:57 AM ET \n\n\n \n\n\n     Source: Dow Jones Market Data, FactSet \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  October 30, 2025 11:40 ET (15:40 GMT)\n\n\n  Copyright (c) 2025 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-2","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"}}}